Dimensional Fund Advisors LP Supernus Pharmaceuticals, Inc. Transaction History
Dimensional Fund Advisors LP
- $363 Billion
- Q1 2024
A detailed history of Dimensional Fund Advisors LP transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,556,921 shares of SUPN stock, worth $67.8 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,556,921
Previous 2,456,369
4.09%
Holding current value
$67.8 Million
Previous $71.1 Million
22.69%
% of portfolio
0.02%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding SUPN
# of Institutions
261Shares Held
57.3MCall Options Held
84.1KPut Options Held
61.2K-
Black Rock Inc. New York, NY10.4MShares$275 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.21MShares$165 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY3.57MShares$94.7 Million1.66% of portfolio
-
Macquarie Group LTD Australia, C32.67MShares$70.8 Million0.1% of portfolio
-
State Street Corp Boston, MA2.04MShares$54 Million0.0% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.42B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...